CASP1 and myalgic encephalomeyelitis/chronic fatigue syndrome: These results, together with other reports underlining the importance of IL-1β in CFS [10, 40], indicated that LPS-induced fatigue is an IL-1β-dependent disorder and that NLRP3/caspase-1 inhibition therapy may be a promising option for anti-fatigue therapy.